Last reviewed · How we verify

NCT04574934

Effect of Aquatic Therapy on Pulmonary Functions in Patients With Muscular Dystrophy

Status unknown NA Last updated 5 October 2020
What this trial tests

NA trial testing aquatic therapy in Muscular Dystrophy in 30 participants. Status unknown.

Timeline
1 June 2020
Primary endpoint
1 October 2020
1 October 2020

Quick facts

Lead sponsorSouth Valley University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 June 2020
Primary completion1 October 2020
Estimated completion1 October 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

South Valley University

Who can join

Adults 4 to 40, any sex, with Muscular Dystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to assess the efficacy of aquatic therapy on pulmonary functions in patients with muscular dystrophy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of aquatic therapy

Trials testing the same drug.

Other recruiting trials for Muscular Dystrophy

Currently open trials in the same condition.

Other South Valley University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04574934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing